Small-molecule drug discovery in triple negative breast cancer: current situation and future directions

M Liao, J Zhang, G Wang, L Wang, J Liu… - Journal of medicinal …, 2021 - ACS Publications
Triple negative breast cancer (TNBC) is the most aggressive subtype of breast cancer, but
an effective targeted therapy has not been well-established so far. Considering the lack of …
被引用次数：75 相关文章

Small-Molecule Drug Discovery in Triple Negative Breast Cancer: Current Situation and Future Directions.

M Liao, J Zhang, G Wang, L Wang, J Liu… - Journal of Medicinal …, 2021 - europepmc.org
Triple negative breast cancer (TNBC) is the most aggressive subtype of breast cancer, but
an effective targeted therapy has not been well-established so far. Considering the lack of …

[引用][C] Small-Molecule Drug Discovery in Triple Negative Breast Cancer: Current Situation and Future Directions

M Liao, J Zhang, G Wang, L Wang, J Liu… - Journal of Medicinal …, 2021 - cir.nii.ac.jp
Small-Molecule Drug Discovery in Triple Negative Breast Cancer: Current Situation and Future
Directions | CiNii Research CiNii 国立情報学研究所 学術情報ナビゲータ[サイニィ] 詳細へ移動 …

Small-Molecule Drug Discovery in Triple Negative Breast Cancer: Current Situation and Future Directions

M Liao, J Zhang, G Wang, L Wang… - Journal of …, 2021 - pubmed.ncbi.nlm.nih.gov
Triple negative breast cancer (TNBC) is the most aggressive subtype of breast cancer, but
an effective targeted therapy has not been well-established so far. Considering the lack of …